Dry Needling in Subjects With Delayed Onset Muscle Soreness

Biomechanical Response to Dry Needling in Subjects With Delayed Onset Muscle Soreness: a Double Blind Randomized Control Trial

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03876080

Acronym

TDNDOMS

Enrollment

Registered

2019-03-15

Start date

2019-03-30

Completion date

2023-05-23

Last updated

2023-07-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Delayed Onset Muscle Soreness

Brief summary

Investigation of the biomechanical response in delayed onset muscle soreness using dry needling vs. sham

Interventions

OTHERDry needling

The use of a solid filiform needle to treat trigger points

OTHERSham needling

Simulated needling

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to 35 Years

Healthy volunteers

Yes

Inclusion criteria

* The participants of the study will be any healthy male or female between * age of 18 to 35 * able and willing to perform an exercise protocol using the gastrocnemius muscle * willing to receive either sham or dry needling intervention

Exclusion criteria

* current muscular pain * prior trigger point therapy in the past 6 months * medications that affect muscle function * injury in the past 6 months * any health condition that prevents exercising * recent surgery

Design outcomes

Primary

Measure	Time frame	Description
Change in Biomechanical stiffness (N/m) using MyotonPRO	baseline, immediately after intervention, 24 hours after intervention	Measuring Biomechanical stiffness ( N/m) change at the following time frames

Secondary

Measure	Time frame	Description
Change in Pressure pain threshold using pressure algometry	baseline, immediately after intervention, 24 hours after intervention	Measuring Pressure pain threshold change at the following time frames

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026